Phase 2 Study to Evaluate Safety and Pharmacodynamics of CS-3150 in Type 2 Diabetes Mellitus Patients with Albuminuria
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Esaxerenone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Daiichi Sankyo Company
- 07 Jun 2016 New trial record